Innoviva Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.7% | +1.9% | -3.4% | +0.5% | +5.6% | -3.6% | +6.3% | +7.2% | +14.4% | +12.3% | -7.3% | |
| – | +12.9% | -9.6% | +15.1% | +11.8% | +38.4% | +5.0% | +12.0% | +5.0% | +6.3% | +6.2% | -2.5% | |
| – | +7.5% | -7.8% | +21.7% | +20.1% | +17.0% | +4.6% | +24.6% | +19.9% | +15.6% | +9.5% | -5.4% | |
| – | +7.5% | -7.8% | +21.7% | +20.1% | +58.3% | +8.3% | +11.4% | +7.1% | +3.3% | +11.1% | -5.4% | |
| – | +24.1% | -9.6% | +23.6% | -3.1% | -5.2% | -9.8% | +13.2% | +6.0% | -62.6% | +164.9% | +19.4% | |
| – | +0.5% | -8.1% | -2.1% | -6.6% | -1.5% | +23.0% | +18.1% | -21.7% | +2.1% | -0.8% | +0.3% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -2.7% | -2.8% | -2.9% | -3.0% | -1.2% | -3.1% | -3.2% | -4.7% | -2.2% | -3.6% | -3.8% | |
| – | +1.4% | -0.8% | -0.8% | +0.7% | +8.3% | -0.4% | +1.9% | -32.3% | +10.3% | +7.1% | -5.1% | |
| – | +5.4% | -21.6% | -5.6% | +693.3% | +5.5% | -0.6% | +5.0% | -80.3% | +2.5% | -26.4% | +28.7% | |
| – | -0.3% | +5.1% | +14.4% | +13,225.6% | +0.1% | -0.1% | -0.3% | -95.6% | -95.0% | +1,177.3% | -86.7% | |
| – | +77.6% | -86.8% | +129.1% | +104.5% | -48.9% | +120.5% | +14.5% | +16.0% | -20.5% | +31.3% | -38.4% | |
| – | +0.1% | +0.1% | +0.1% | -42.8% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | |
| – | +7.6% | +4.3% | -5.4% | +0.5% | +3.4% | -6.4% | +10.5% | +41.3% | +16.1% | +14.4% | -8.1% | |
| – | – | – | -305.8% | – | – | – | – | +587.4% | +156.0% | +69.3% | -18.3% | |
| – | -1.4% | -0.5% | -26.0% | +0.7% | +33.8% | -25.5% | +34.7% | +0.6% | +0.4% | -0.5% | -13.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.